Congress must fix the No Surprises Act before it bankrupts patients and employers, James Gelfand and Patricia Kelmar write.

The farm bill shows politicians catering to the agriculture industry risk losing the support of MAHA while running afoul of ...

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about ...

A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private ...

What's changed now is that there's a view in this administration that everything is political,” said Robert Califf, former ...

Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be considered cost-effective.

Looking to bolster its pipeline, Novartis is buying a breast cancer drug candidate for $2 billion from Delaware-based Synnovation Therapeutics.

In recent years, a growing outcry has drawn long-overdue attention to a difficult truth: girls’ and women’s pain has too often been dismissed and undertreated in medicine. A 2022 study found that most ...

The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund research in the understanding and treatment of bipolar disorder and schizophrenia research.

A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries to claw back market share with its ...

Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT event on Thursday.

A U.S. district judge said he will vacate a declaration by Kennedy that asserted gender-affirming care for young trans people does not meet medical standards of care.